StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a report issued on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $10.00 price target on shares of CASI Pharmaceuticals in a research note on Monday, August 14th. […]
CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.41 and traded as high as $2.55. CASI Pharmaceuticals shares last traded at $2.49, with a volume of 7,682 shares traded. Wall Street Analysts Forecast Growth A […]
StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and set a $10.00 price target on shares of CASI Pharmaceuticals in a report on Monday, August 14th. […]
CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a note issued to investors on Monday, Benzinga reports. They currently have a $10.00 price objective on the biotechnology company’s stock. HC Wainwright’s price objective suggests a potential upside of 340.53% from the company’s current […]
StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Performance CASI opened at $2.51 on Tuesday. CASI Pharmaceuticals has a twelve month low of $1.45 and a twelve […]